ID
26499
Beschrijving
Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 Study Drug Compliance
Trefwoorden
Versies (1)
- 18/10/2017 18/10/2017 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
18 de outubro de 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC-ND 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Study Drug Compliance Ropinirole in Parkinson's Disease GSK 101468/196
Study Drug Compliance Ropinirole in Parkinson's Disease GSK 101468/196
Beschrijving
Study Drug Compliance - If there were missed doses, please indicate the details below if additional space per visit is required.
Alias
- UMLS CUI-1
- C1321605
- UMLS CUI-2
- C0304229
Beschrijving
Date
Datatype
date
Maateenheden
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0011008
Beschrijving
Tablet
Datatype
text
Alias
- UMLS CUI [1]
- C0039225
Beschrijving
Dosage
Datatype
float
Maateenheden
- mg
Alias
- UMLS CUI [1]
- C0178602
Beschrijving
Reason
Datatype
text
Alias
- UMLS CUI [1]
- C0392360
Similar models
Study Drug Compliance Ropinirole in Parkinson's Disease GSK 101468/196
C0304229 (UMLS CUI-2)